T cell responses during human immunodeficiency virus (hiv)-1 infection

Claire A. Chougnet, Barbara Shacklett

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The defining features of the acquired immunodeficiency are the-persistent and profound selective decrease in the function as well as number of T lymphocytes of the helper/inducer subset and a possible activation of the suppressor/cytotoxic subset, as described in 1982 (Mildvan, D., U. Mathur, et al. (1982). Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 96(6 Pt 1): 700-4). Nowadays, although depletion of CD4+ T-cells remains a hallmark of Human Immunodeficiency Virus (HIV) infection, the multifactorial nature of the disease provoked by infection by HIV-1 or Simian Immunodeficiency Virus (SIV) in non-natural hosts is generally acknowledged, in that no unique immune alteration has been identified that can fully explain the plethora of dysregulation associated with the development of pathogenic HIV and SIV infection. This review will focus on what we know (or do not know) about T cell responses during HIV infection. This choice reflects the main expertise of the authors, and the major theme of this book. However, other aspects of adaptive and innate immunity should not be overlooked. Notably, HIV-specific antibodies, including neutralizing antibodies, are an important defense of the adaptive immune system, although HIV appears to quickly evade the effect of these antibodies. Recent studies have also highlighted the role of innate immunity in protection against HIV/SIV. In addition, several cellular antiretroviral restriction factors, either constitutively expressed or induced by interferons, have been identified, which provide considerable-resistance to retroviral infection. For more on these topics, we refer readers to recent reviews summarizing these crucial aspects of the virus/host interaction (Kuritzkes, D. R. and B. D. Walker (2007). HIV-1 Pathogenesis, Clinical Manifestations and Treatment. Fields Virology. D. Knipe and P. M. Howley. Philadelphia, PA, Lippincott Williams & Wilkins. 2: 2187-2214; Levy, J. A. (2007). HIV and the Pathogenesis of AIDS. Washington, D.C., ASM Press; Zwick, M. B. and D. R. Burton (2007). HIV-1 neutralization: mechanisms and relevance to vaccine design. Curr HIV Res 5(6): 608-24; Alter, G. and M. Altfeld (2009). NK cells in HIV-1 infection: evidence for their role in the control of HIV-1-infection. J Intern Med 265(1): 29-42; Neil, S. and P. Bieniasz (2009). Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29(9): 569-80; Stamatatos, L., L. Morris, et al. (2009). Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat Med 15(8): 866-70; Strebel, K., J. Luban, et al. (2009). Human cellular-restriction factors that target HIV-1 replication. BMC Med 7: 48; Altfeld, M., L. Fadda, et al. (2011). DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 11(3): 176-86).

Original languageEnglish (US)
Title of host publicationControl of Innate and Adaptive Immune Responses during Infectious Diseases
PublisherSpringer New York
Pages141-169
Number of pages29
Volume9781461404842
ISBN (Electronic)9781461404842
ISBN (Print)1461404835, 9781461404835
DOIs
StatePublished - Oct 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Chougnet, C. A., & Shacklett, B. (2012). T cell responses during human immunodeficiency virus (hiv)-1 infection. In Control of Innate and Adaptive Immune Responses during Infectious Diseases (Vol. 9781461404842, pp. 141-169). Springer New York. https://doi.org/10.1007/978-1-4614-0484-2_8